bottom line equal weight rate thermo-fish scientif
reflect view end market condit dont support
acceler growth believ necessari drive
stock out-performance current level absent meaning capit
deploy tmo organ growth guidanc consensu
support thesi
pharma/biotech outlook look strong could conserv
despit manag increas confid year
pharma/biotech end market tmo largest exposur grow
ahead compani growth framework rang still guid
bottom end full year compani note tri
reflect caution could materi headwind
year due approach compani increas
confid biopharma outlook believ could
upsid potenti expect
china headwind emerg fourth quarter growth
china low-singl digit fell short mid-singl digit expect
manag note quarter growth limit delay
releas
capit equip purchas
govern entiti in-lin anecdot check
privat tool compani discuss quarterli preview
note link expect environ improv
catch delay revenu later year check lead
us bit cautiou full year compani expect
china growth double-digit rang compar last year
model updat updat estim
 note herein
lower price target
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
conform compani non-gaap present exclud acquir intang
conform compani non-gaap present exclud acquir intang
conform compani non-gaap present exclud acquir intang
conform compani non-gaap present exclud acquir intang
compani data secur llc estim reuter
price target
price target reflect enterpris valu use project level debt cash
ebitda ex option multipl premium life scienc tool
diagnost high qualiti industri peer group believ appropri given prospect
consist double-digit earn growth downsid risk equal weight rate includ
limit follow factor first given view compani organ end market exposur
support acceler growth see acquisit target select integr risk potenti
headwind go forward secondli due compani intern footprint global macro
deterior particular deterior demand trend china would weigh futur growth
prospect well worsen academic/govern fund trend slowdown demand
upsid risk equal weight rate includ stronger expect growth compani gener
end market within specif custom mix lead improv growth outlook well
compani execut deliv accret deal investor bullish could addit
upsid compar equal weight rate
equal weight rate thermo-fish scientif reflect view end market condit
support acceler growth believ necessari drive stock out-performance
waltham massachusetts-bas thermo fisher scientif inc nyse provid wide rang
analyt instrument consum research appli use life scienc industri not-
for-profit end market compani also signific provid specialti diagnost clinic
end market thermo fisher balanc revenu mix end market exposur compani
extens distribut also distinguish featur
thermo fisher oper four segment analyt instrument ai life scienc solut lss
specialti diagnost sd laboratori product servic lp ai three primari
busi chromatographi mass spectrometri chemic analysi environment process
instrument lss hold legaci bioscienc busi well life technolog
busi sd five primari busi immunodiagnost clinic diagnost microbiolog
anatom patholog healthcar market custom channel lp four primari busi
laboratori equip laboratori consum research safeti market custom channel
